we keep life real and safe by providing botanical-dna based security and authentication solutions and services that protect assets, products, brands, supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Company profile
Ticker
APDN, APPDW
Exchange
Website
CEO
James Hayward
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
PROHEALTH MEDICAL TECHNOLOGIES INC, DCC ACQUISITION CORP, DATALINK CAPITAL CORP/TX/
SEC CIK
Corporate docs
Subsidiaries
APDN (B.V.I.) Inc. • Applied DNA Sciences Europe Limited • Applied DNA Sciences India Private Limited • LineaRX, Inc. • Applied DNA Clinical Labs LLC • Spindle Biotech, Inc. ...
IRS number
592262718
APDN stock data
Latest filings (excl ownership)
S-1/A
IPO registration (amended)
24 May 24
S-1/A
IPO registration (amended)
22 May 24
S-1/A
IPO registration (amended)
21 May 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
16 May 24
S-1/A
IPO registration (amended)
14 May 24
8-K
Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
10 May 24
10-Q
2024 Q2
Quarterly report
10 May 24
8-K
Regulation FD Disclosure
1 May 24
S-1
IPO registration
23 Apr 24
8-K/A
Amendments to Articles of Incorporation or Bylaws
23 Apr 24
Transcripts
APDN
Earnings call transcript
2024 Q1
8 Feb 24
APDN
Earnings call transcript
2023 Q4
7 Dec 23
APDN
Earnings call transcript
2023 Q3
10 Aug 23
APDN
Earnings call transcript
2023 Q3
10 Aug 23
APDN
Earnings call transcript
2023 Q2
12 May 23
APDN
Earnings call transcript
2023 Q1
9 Feb 23
APDN
Earnings call transcript
2022 Q4
17 Dec 22
APDN
Earnings call transcript
2022 Q3
11 Aug 22
APDN
Earnings call transcript
2022 Q2
14 May 22
APDN
Earnings call transcript
2022 Q1
10 Feb 22
Latest ownership filings
SC 13G
Leviticus Partners LP
1 May 24
SC 13G
Grossman Bruce
12 Feb 24
SC 13G/A
AWM Investment Company, Inc.
10 Jan 24
4
Beth Jantzen
27 Mar 23
4
Clay Shorrock
27 Mar 23
4
Judith Murrah
27 Mar 23
SC 13G
AWM Investment Company, Inc.
14 Feb 23
SC 13G/A
Grossman Bruce
9 Feb 23
4
YACOV A SHAMASH
27 Jan 23
4
Scott L Anchin
27 Jan 23
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 23 | Sep 22 | Sep 21 | Sep 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.90 mm | 3.90 mm | 3.90 mm | 3.90 mm | 3.90 mm | 3.90 mm |
Cash burn (monthly) | 69.80 k | 761.47 k | 1.50 mm | 1.30 mm | 1.07 mm | 918.05 k |
Cash used (since last report) | 135.10 k | 1.47 mm | 2.90 mm | 2.51 mm | 2.07 mm | 1.78 mm |
Cash remaining | 3.76 mm | 2.43 mm | 1.00 mm | 1.39 mm | 1.83 mm | 2.12 mm |
Runway (months of cash) | 53.9 | 3.2 | 0.7 | 1.1 | 1.7 | 2.3 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 31 |
Opened positions | 5 |
Closed positions | 3 |
Increased positions | 6 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 3.20 bn |
Total shares | 2.79 mm |
Total puts | 9.10 k |
Total calls | 91.80 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
AWM Investment | 808.81 k | $994.83 mm |
AMH Equity | 587.23 k | $710.55 mm |
Vanguard | 523.69 k | $633.67 mm |
Susquehanna International | 140.19 k | $172.44 mm |
Hirschman Orin | 140.00 k | $620.00 k |
Geode Capital Management | 139.19 k | $171.26 mm |
BLK Blackrock | 101.66 k | $123.01 mm |
Atria Wealth Solutions | 81.01 k | $98.02 mm |
STT State Street | 75.68 k | $93.08 mm |
Raymond James & Associates | 49.88 k | $60.35 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Mar 23 | Jantzen Beth | Common Stock | Grant | Acquire A | No | No | 0 | 91,667 | 0.00 | 91,739 |
23 Mar 23 | Jantzen Beth | NQSO Common Stock | Grant | Acquire A | No | No | 1.08 | 1,961 | 2.12 k | 1,961 |
23 Mar 23 | Jantzen Beth | Incentive Stock Option Common Stock | Grant | Acquire A | No | No | 1.08 | 98,039 | 105.88 k | 98,039 |
23 Mar 23 | Clay Shorrock | Common Stock | Grant | Acquire A | No | No | 0 | 91,667 | 0.00 | 91,667 |
23 Mar 23 | Clay Shorrock | NQSO Common Stock | Grant | Acquire A | No | No | 1.08 | 1,961 | 2.12 k | 1,961 |
23 Mar 23 | Clay Shorrock | Incentive Stock Option Common Stock | Grant | Acquire A | No | No | 1.08 | 98,039 | 105.88 k | 98,039 |
23 Mar 23 | Murrah Judith | Common Stock | Grant | Acquire A | No | No | 0 | 99,306 | 0.00 | 101,853 |
23 Mar 23 | Murrah Judith | NQSO Common Stock | Grant | Acquire A | No | No | 1.08 | 10,294 | 11.12 k | 10,294 |
23 Mar 23 | Murrah Judith | Incentive Stock Option Common Stock | Grant | Acquire A | No | No | 1.08 | 98,039 | 105.88 k | 98,039 |
25 Jan 23 | Catell Robert B | NQSO Common Stock | Grant | Acquire A | No | No | 1.41 | 39,428 | 55.59 k | 39,428 |
News
Crude Oil Rises Sharply; Elbit Systems Shares Fall After Q1 Results
28 May 24
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
28 May 24
12 Health Care Stocks Moving In Tuesday's Intraday Session
28 May 24
Dow Dips Over 100 Points; GameStop Shares Spike higher
28 May 24
US Stocks Mixed; Home Prices Increase In March
28 May 24
Press releases
Applied DNA Announces Pricing of $12 Million Public Offering
28 May 24
Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
10 May 24
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
10 May 24
Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program
25 Apr 24
Applied DNA Announces 1-For-20 Reverse Stock Split
22 Apr 24